Alloimmunization in Thalassemia Patients: New Insight for Healthcare

Development of alloantibodies against the foreign red blood cell (RBC) (alloimmunization) is a well‑known complication in thalassemia patients when performing multiple transfusions. The study was conducted to know the prevalence of alloimmunization in thalassemia patients, in the Caspian Sea coastline.
This study is a descriptive, retrospective analysis of transfusion records of 190 patients with β‑thalassemia major who received regular transfusions. To detect the type of alloantibodies, two cells panel tests (kits; Iranian Blood Transfusion Organization [IBTO], 3 RBC cells and IBTO, 11 RBC cells) were used.
Forty‑seven patients were positive for alloantibodies (24.7%). Of them, 18.4% (35 cases) had only one alloantibody, and 6.3% (12 cases) had at least two or more of alloantibodies. The vast majority of alloantibodies were anti‑Kell followed by anti‑E, and anti‑D, respectively.
Blood matching for Rh and K antigens in patients with transfusion‑dependent thalassemia could reduce the rate of RBC alloinununization.